Crossmark

Vitamin D as an Adjuvant Immune Enhancer to SARS-Cov-2 Vaccine

Crossref DOI link: https://doi.org/10.1007/s00284-025-04095-3

Published Online: 2025-02-07

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salamony, Azza https://orcid.org/0000-0003-4606-2779
Abdelsalam, Maha https://orcid.org/0000-0002-8160-8960
Elguindy, Nancy https://orcid.org/0000-0002-5876-237X
Roshdy, Wael H. https://orcid.org/0000-0001-8412-3128
Youssef, Amr https://orcid.org/0000-0002-2142-7762
Shamikh, Yara https://orcid.org/0000-0001-7535-459X
License Information

Text and Data Mining valid from 2025-02-07

Version of Record valid from 2025-02-07
More Information

Article History

Received: 26 May 2024

Accepted: 16 October 2024

First Online: 7 February 2025

Declarations

:

: The authors declared that they have no conflict of interest.

: Approved by central public health.